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Background: Methylphenidate, a medication prescribed for individuals suffering from attention-
deficit/hyperactivity disorder, is increasingly being misused by students.
Objective: The aims of this study were to evaluate the frequency of methylphenidate use among 
a group of Iranian medical students and to assess their knowledge of methylphenidate.
Methods: Anonymous, self-administered questionnaires were completed by all medical students 
entering the university between 2000 and 2007.
Results: Methylphenidate users’ mean knowledge score was higher than that of nonusers 
(15.83 ± 3.14 vs 13.66 ± 3.10, P = 0.008). Age, gender, and school year were positively c  orrelated 
with knowledge score (P , 0.05). Data analysis demonstrated that 27 participants (8.7%) had 
taken methylphenidate at least once in their lifetime. The respondents believed that the most 
common motive for methylphenidate use among youths was that it aided concentration and 
therefore ability to study.
Conclusion: This study indicates a relatively low level of knowledge about m  ethylphenidate 
among Iranian medical students. More educational programs regarding the use of m  ethylphenidate 
are required and should be focused on the student suppliers, clinicians, pharmacists, and   medical 
students.
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Introduction
According to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, 
Text Revision (DSM-IV-TR), substance abuse is a mental disorder in which the use of a 
substance reaches a point th at induces significant dysfunction in the life of the abuser.1 
Among such substances, prescription stimulants are assumed to be harmless ways of 
increasing levels of energy and concentration, enhancing school performance, or using 
for recreation, while lessening the desire for sleep.2 Youths show a high predilection 
for the use of prescription stimulants.3
Methylphenidate (Ritalin) is a medication prescribed for individuals, in particular 
children, who have attention-deficit/hyperactivity disorder (ADHD).4 The attention-
improving characteristic of methylphenidate has been attributed to the amplification of 
dopamine release in the central nervous system.5,6 There is an increasing trend toward 
the misuse of methylphenidate by youths. However, some research has concluded 
that methylphenidate use is exclusive to college students, because less use was found 
in a nonstudent population of the same age range.3 Methylphenidate is known for its 
high abuse potential; it has the same effects as cocaine or amphetamines5 and is the 
most widely researched of the prescription stimulant drugs.7,8 Cases of oral, intranasal, Drug Design, Development and Therapy 2011:5 submit your manuscript | www.dovepress.com
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and intravenous abuse of the drug are well documented.9,10 
The latter, a less common route of administration, can be 
p  recarious because fillers in the pills could block small blood 
vessels, causing injury to lungs and eyes.11 However, when 
methylphenidate is administered at high doses intranasally 
or orally, the risk of addiction increases and the physical side 
effects are augmented.5,9 No well-controlled studies have 
hitherto investigated methylphenidate tolerance, but clini-
cians and patients have reported situations where decreased 
efficacy and psychological dependence appear to occur.12
In recent years, researchers have investigated the illicit 
use of stimulants prescribed for the treatment of ADHD 
among American college students.13 Teter et al indicated that 
3% of students surveyed at a large public university used 
methylphenidate for nonmedical purposes.14 Furthermore, 
Dupont et al reported that more than 5% of approximately 
2000 c  ollege students used methylphenidate nonmedically 
at least once.15 Interestingly, Low and Gendaszek reported a 
prevalence of 35% among undergraduates in a psychology 
class for the misuse of methylphenidate or amphetamine.16 
Prescription stimulant misuse ranges from 5% to 35% in 
college-aged individuals (for a review, see Wilens et al17).
Demanding times throughout the academic year, i  ncluding 
final e  xaminations, can lead to an increased demand 
for prescription stimulants such as methylphenidate.9,17 
  Appetite s  uppression, w  akefulness, increased a  ttentiveness, 
and   euphoria are known to be stimulant effects of 
methylphenidate.5
These data provide some understanding of the prevalence 
of methylphenidate abuse, particularly in the US and Canada. 
No corresponding data are available from other countries, 
and an in-depth description of the users’ conceptions and 
choices is lacking. A few recent studies have focused on 
various health topics among Iranian medical students,18–20 but 
there has been no research examining the prevalence and cor-
relation of nonmedical use of methylphenidate among such 
students. Therefore, this study was carried out to determine 
the frequency of methylphenidate use among a group of 
Iranian medical students and to assess their knowledge of 
methylphenidate.
Methods
The study population comprised all medical students e  ntering 
the Faculty of Medicine, Tabriz University of Medical 
Sciences, Tabriz, Iran, between 2000 and 2007. A self-
administered, anonymous questionnaire based on information 
obtained from a review of the literature on methylphenidate 
was utilized. The questionnaires were distributed among 
all the medical students from the first (2007 entrance) to 
s  eventh (2000 entrance) school year who were present at 
daily classes and/or hospital wards between January and 
March 2007. The reliability and validity of the questionnaire 
were qualified and examined by a pilot study and the supervi-
sion of expert professors. The questionnaire comprised four 
s  ections: 1) de  mographic information including age, gender, 
marital status, living place, and average grade of participants 
(five items); 2) methylphenidate-related questions covering 
general information, clinical symptoms, and legal aspects 
(11 items); 3) questions to determine the frequency of 
methylphenidate use (two items); and 4) a multiple-choice 
question regarding the respondents’ perceptions of the rea-
sons for the increasing tendency toward methylphenidate 
use (one item).
Concerning knowledge about methylphenidate, the 
s  ection began with a question on whether individuals 
had heard of methylphenidate. This was followed by a 
q  uestion about the source of the respondents’ information 
(mass media, medical books, scientific journals, Internet, 
friends, or a   physician’s prescription). In addition, there 
were 11 s  tatements concerning students’ knowledge of 
m  ethylphenidate, and possible responses for this section 
included “true”, “false”, and “I don’t know”. The   knowledge 
score was calculated by allocating +2 for a correct answer, 
0 for an incorrect answer, and +1 for “I don’t know” 
responses. A total of 22 points could be achieved if all ques-
tions were answered correctly. Higher scores were indicative 
of a greater level of knowledge.
In order to determine the frequency of methylpheni-
date use among the students, they were asked whether 
they had used methylphenidate, excluding those who had 
been prescribed the medication. If respondents replied in 
the a  ffirmative to this question they answered a follow-up 
question relating to how often they used methylphenidate. 
Possible responses for this question included “used before 
last year”, “used in the past 12 months”, “used in the past 
6 months”, and “used in the past 30 days”. In addition,   
a question relating to the preferred route of administration 
was included in the questionnaire.
Additional questions concerning the reasons for t  aking 
prescription stimulant medications were posed to all 
r  espondents. Students were given the option to choose any 
of the response categories including increasing wakefulness, 
peer pressure, curiosity, increasing self-confidence, weight 
loss, increasing concentration, and euphoric effects.
Data were presented as the mean ± standard deviation, 
or percentage when appropriate. All statistical analyses Drug Design, Development and Therapy 2011:5 submit your manuscript | www.dovepress.com
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were performed with SPSS (SPSS Inc, Chicago, IL, USA) 
for Windows, Version 16.0, using a Chi-square test, Fisher’s 
exact test, and independent samples t-test. Spearman’s cor-
relation coefficient was calculated to determine the correla-
tion between quantitative variables (demographic items and 
total knowledge score). A P value ,0.05 was considered 
statistically significant.
Results
Of 500 medical students, 310 completed the questionnaire, 
representing a response rate of 62%. The mean age of the 
respondents was 21.4 ± 2.07 years (range 18–28 years). Forty-
three percent (n = 134) of the students were male and 56.7% 
(n = 176) were female. The students’ mean grade average was 
15.4 ± 1.3 out of 20 (range 12.4–18.8). A list of the knowledge 
questions with the percentage of each response is provided in 
Table 1. Methylphenidate users’ mean knowledge score (total 
of correct and incorrect responses) was higher than that of 
nonusers (15.83 ± 3.14 vs 13.66 ± 3.10, Table 2, P = 0.008). 
Among the   demographic items, age (r = 0.29; P = 0.001), 
gender (r = 0.22; P = 0.015), and school year (r = 0.28; 
P = 0.001) were positively   correlated with the knowledge 
score. There was no significant c  orrelation between other 
demographic items (grade a  verage, marital status, and place 
of residence) and knowledge score (P . 0.05).
Data analysis demonstrated that 27 participants (8.7%) 
had taken methylphenidate at least once in their lifetime; 
two students were excluded from the study because they 
misused methylphenidate while under a physician’s order. 
Of these 27 individuals, 20 (74%) declared that they had 
taken methylphenidate within the last year and three (11%) 
within the last month. Ninety-seven participants (31.2%) 
knew   someone among their classmates and friends who had 
misused m  ethylphenidate. The frequency of m  ethylphenidate 
use was significantly higher among men than among 
women (92% vs 8%, Table 2, P , 0.001). F  urthermore, 
m  ethylphenidate use was significantly higher among 
respondents with a grade average of 15 or less (74%) than 
among students with higher grade averages (Chi-square test, 
P , 0.001). M  ethylphenidate had previously been prescribed 
by physicians for three of the users (11%), and six students 
(22.2%) indicated that they were encouraged by their peers 
to take methylphenidate for its positive effects. The preferred 
route of administration was oral (88.8%), followed by nasal 
(3.7%) and injection (3.7%). Many of the respondents (21%) 
indicated that friends were the major source of information 
concerning methylphenidate, followed by scientific books 
and journals (17.6%), mass media (radio, television, and 
newspapers) (4.2%), and the Internet (3.4%). The data 
from respondents and methylphenidate users are provided 
in Table 2.
Respondents believed that the most common motive for 
methylphenidate use was to increase concentration (41.7%). 
Furthermore, students declared that increasing wakeful-
ness (17.3%), curiosity (16.7%), increasing energy levels 
(8.8%), increasing self-confidence (6.1%), peer pressure 
(5%), and weight loss (4.4%) were also common reasons for 
methylphenidate misuse.
Discussion
In the present study, the prevalence of methylphenidate 
m  isuse among a group of Iranian medical students was 
assessed along with their knowledge of methylpheni-
date. Data a  nalysis demonstrated that less than 9% of 
medical s  tudents had used methylphenidate at least once 
in their   lifetime. Of those who admitted to using the drug, 
a  pproximately 75% had taken methylphenidate in the 
past year and 10% in the last 30 days. A wide range of 
Table 1 The respondents’ knowledge of methylphenidate (n = 310)
Statement True (%) False (%) I do not know (%)
  1. Methylphenidate is an illicit prescription drug. 44.9 40.8 14.2
  2. Methylphenidate carriers are criminal. 32.9 10.7 56.2
  3. increased concentration is one of its positive effects. 50 3.2 45.7
  4.   A person who uses methylphenidate can have high mental activity  
for hours without needing to relax.
40.4 5.9 53.5
  5. Methylphenidate is advised for weight loss. 13.2 10.8 75.9
  6. Positive effects of methylphenidate last only several hours. 39 6 54.8
  7. Methylphenidate has no medical use. 45.7 11.4 43.3
  8. Methylphenidate can cause increased hunger. 19.2 7.8 72.8
  9. Methylphenidate decreases learning. 31.3 7.8 60.8
10. Methylphenidate causes low heart rate. 29.1 8.6 62.1
11.   Methylphenidate has no characteristics of addictive drugs and users  
do not become dependent.
37.3 8.4 54.2Drug Design, Development and Therapy 2011:5 submit your manuscript | www.dovepress.com
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m  ethylphenidate use has been reported in the literature.13,17 
Teter et al surveyed a large sample of public university 
students among whom 3% indicated nonmedical use of 
methylphenidate within the previous year.14 A  ccording to 
the Monitoring the Future (MTF) study, annual use of meth-
ylphenidate among college students was 4.2% and 3.9% in 
2005 and 2006, respectively.3 In another study by Teter et al, 
approximately 25% of illicit users of p  rescription stimulants 
used methylphenidate.21 In contrast, Low and Gendaszek 
indicated that 35% of 150 undergraduates in a psychology 
class had used either methylphenidate or amphetamine at 
least once.16 In the present study, approximately 30% of 
respondents knew someone among their classmates and 
friends who had misused methylphenidate. The difference 
between the two calculated prevalences of methylphenidate 
use among the surveyed group of medical students (8.8% vs 
31.2%) might suggest that students felt more comfortable 
about reporting methylphenidate use by their peers than by 
themselves, despite the anonymity of the questionnaires. 
However, this difference could also be due to overlap 
between the reports, ie, one particular methylphenidate user 
could be reported by himself/herself and his/her friends 
simultaneously. To the best of our knowledge, the present 
study is the first survey to determine the frequency of meth-
ylphenidate misuse among a group of medical students and 
to assess their knowledge of methylphenidate.
The overall findings from this study indicate a relatively low 
level of knowledge concerning methylphenidate, its p  hysiological 
and psychological side effects, or legal consequences of illicit 
use among the medical students surveyed. H  owever, the stu-
dents’ knowledge score increased the longer they had been 
studying at the university. Assessing the knowledge of the 
university students with regard to methylphenidate has been 
neglected in most previous research, though DeSantis et al indi-
cated that most users among undergraduates at a southeastern 
research university in the US possessed limited knowledge of 
prescription stimulants, including methylphenidate.13
In accordance with the MTF study, men reported higher 
past-year rates of methylphenidate misuse than women did.3 
Hall et al22 and Simoni-Wastila23 found a comparable 
gender difference in the misuse of methylphenidate. This 
study presented a comparable finding, but the frequency 
of m  ethylphenidate misuse among men was much higher 
than among women (92% vs 8%). In contrast, Teter et al 
reported that undergraduate men and women used illicit 
methylphenidate equally.14 In the present study, medical 
students with lower grade point averages were more likely to 
use methylphenidate illicitly. This finding is similar to those 
of the surveys carried out by McCabe et al.24,25 Furthermore, 
in the present study, methylphenidate use was reported most 
frequently among single medical students who resided on 
campus, but this was not statistically significant.
Table 2 students’ and illicit methylphenidate users’ demographic characteristics
Student characteristics All the respondents 
(n = 310)
Methylphenidate users  
(n = 27)
P value
Age (years) 21.41 ± 2.07 21.94 ± 2.12 0.33b
grade average (out of total 20) 15.48 ± 1.30 14.31 ± 1.50 ,0.001a,b
Knowledge score 13.87 ± 3.17 15.83 ± 3.14 0.008a,b
gender, n (%)
  Male 134 (43.3) 25 (92.5) ,0.001a,c
  Female 176 (56.7) 2 (7.5)
Marital status, n (%)
  Married 17 (5.5) 0 (0) 0.29c
  single 293 (94.5) 27 (100)
Place of residence, n (%)
  With family 129 (41.7) 7 (26) 0.59d
  Dormitory 144 (46.4) 18 (66.6)
  rented house 37 (11.9) 2 (7.4)
school year, n (%)
  1st year 56 (18.1) 2 (7.4) 0.17d
  2nd year 21 (6.8) 4 (14.8)
  3rd year 69 (22.1) 6 (22.2)
  4th year 56 (18.1) 7 (26)
  5th year 56 (18.1) 4 (14.8)
  6th year 31 (10) 0 (0)
  7th year 21 (6.8) 4 (14.8)
Notes: aStatistically significant (P , 0.05); bindependent samples t-test; cFisher’s exact test; dchi-square test.Drug Design, Development and Therapy 2011:5 submit your manuscript | www.dovepress.com
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Individuals misuse methylphenidate and other   stimulants 
to keep alert and improve concentration as they prepare for 
tests or complete term papers.26 Teter et al reported that 
the majority of methylphenidate users among s  urveyed 
students used methylphenidate to enhance their academic 
performance by increasing concentration and alertness.27 
Two recent s  urveys of Iranian pharmacists and g  eneral 
p  ractitioners d  emonstrated that the majority of the   respondents 
believed that Ritalin was used to increase attention and 
concentration.28,29 Likewise, in this study, the m  ajority of 
the respondents, including the m  ethylphenidate users, high-
lighted that increased concentration was the most common 
motive for the use of methylphenidate. However, Barrett et al 
stated that 70% of methylphenidate users administered it for 
recreational reasons.10
In the present study, the most common routes of 
m  ethylphenidate administration were oral (89%), i  ntranasal 
(3.7%), and injection (3.7%). The predominantly oral 
m  ethylphenidate misuse in this study is consistent with 
p  revious reports.10,15,21,30 Interestingly, Teter et al reported 
smoking as another route of methylphenidate a  dministration, 
but this was not evident in the present research.21 In the 
present study, friends were the main source of information. 
This finding is in contrast to our previous reports concern-
ing medical and female high school students’ knowledge of 
bird flu18 and HIV/AIDS31 in the same city, which revealed 
that the mass media were the main source of information.18,31 
In p  revious reports, Iranian pharmacists and general practitio-
ners stated that they obtained information on methylphenidate 
from the mass media and medical journals.28,29
This study has certain limitations. First, the validity 
of self-reported methylphenidate use among respondents 
depends on their willingness to reply truthfully on the ques-
tionnaire. Second, the sample in the present study was from 
a single university, thereby necessitating similar studies be 
conducted in other medical schools for comparison. Third, the 
present study did not explicitly address duration or frequency 
of methylphenidate use. Therefore, it is unknown whether 
nonprescription users took methylphenidate regularly or only 
occasionally. Fourth, the response rate in the present study 
was relatively low (62%). It is possible that the prevalence 
of methylphenidate misuse was underestimated if those who 
misused the drug chose not to complete the survey (eg, for 
fear of lack of anonymity). However, it should be   highlighted 
that this study is the first to estimate the prevalence of 
  methylphenidate use among medical students.
As methylphenidate is legally available to a small group of 
students (student suppliers) as ADHD medication, the authors 
believe that focusing on the small group of student suppliers 
may be an effective intervention approach to addressing the 
current problem of methylphenidate misuse among university 
students. Hence, the medical community, including clinicians 
and pharmacists, may consider reducing the monthly alloca-
tion of pills. In addition, clinicians should counsel students 
regarding the probable serious adverse effects to health if 
methylphenidate is misused, as well as the potential legal 
consequences of misuse. Furthermore, training health care 
professionals and medical students is of great importance 
in controlling the current trend. The findings of this study 
should be considered seriously by local health centers. Being 
aware of the scope and context of the problem could aid the 
development of prevention and monitoring programs for pre-
scription drug misuse and diversion. The relatively low level 
of knowledge concerning methylphenidate among medical 
students in this study is primarily a reflection of insufficient 
academic courses in the medical school curriculum. It is 
recommended that knowledge of medical students about 
this topic be improved through access to textbooks, articles, 
seminars, and specific courses. Moreover, the addition of 
the topic of stimulant drugs, including methylphenidate, to 
pharmacology, toxicology, and psychiatry courses during 
medical education is advised.
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